Upgrade to SI Premium - Free Trial

BioNTech SE (BNTX)

91.29 +0.12 (0.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026 October 20, 2026 6:45 AM - StreetInsider Form 6-K BioNTech SE For: Oct 19 October 19, 2026 7:26 AM - SEC Filing BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026 October 19, 2026 6:45 AM - StreetInsider U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider BioNTech (BNTX) PT Lowered to $132 at Canaccord October 14, 2026 6:35 AM - StreetInsider Form 6-K BioNTech SE For: Oct 13 October 13, 2026 4:09 PM - SEC Filing BioNTech stock falls after cancer trial misses key endpoint October 13, 2026 7:59 AM - StreetInsider BioNTech cancer trial misses progression-free survival endpoint October 13, 2026 6:45 AM - StreetInsider BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer  October 13, 2026 6:45 AM - StreetInsider Form 4 BioNTech SE For: Oct 08 Filed by: Sahin Ugur October 9, 2026 4:47 PM - SEC Filing Argus Starts BioNTech (BNTX) at Hold October 8, 2026 8:40 AM - StreetInsider Form 4 BioNTech SE For: Oct 07 Filed by: Sahin Ugur October 7, 2026 5:14 PM - SEC Filing BioNTech (BNTX) PT Lowered to $114 at Morgan Stanley October 7, 2026 7:58 AM - StreetInsider Novavax and Moderna shares fall after plague concerns ease, Citi comments October 7, 2026 5:06 AM - StreetInsider Form 4 BioNTech SE For: Oct 05 Filed by: Sahin Ugur October 6, 2026 4:59 PM - SEC Filing Form 4 BioNTech SE For: Oct 01 Filed by: Sahin Ugur October 2, 2026 4:28 PM - SEC Filing Form 4 BioNTech SE For: Sep 29 Filed by: Sahin Ugur September 30, 2026 4:30 PM - SEC Filing Form 4 BioNTech SE For: Sep 25 Filed by: Sahin Ugur September 28, 2026 5:17 PM - SEC Filing BioNTech to close Germany and Singapore sites after sale fails September 28, 2026 9:07 AM - StreetInsider Form 4 BioNTech SE For: Sep 23 Filed by: Sahin Ugur September 24, 2026 4:26 PM - SEC Filing Form 4 BioNTech SE For: Sep 21 Filed by: Sahin Ugur September 22, 2026 5:04 PM - SEC Filing Form 4 BioNTech SE For: Sep 17 Filed by: Sahin Ugur September 18, 2026 4:42 PM - SEC Filing Form 6-K BioNTech SE For: Sep 18 September 18, 2026 4:10 PM - SEC Filing Form 4 BioNTech SE For: Sep 15 Filed by: Sahin Ugur September 16, 2026 4:46 PM - SEC Filing UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates September 16, 2026 8:40 AM - StreetInsider BioNTech (BNTX) PT Raised to $140 at Berenberg September 16, 2026 4:57 AM - StreetInsider A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat September 15, 2026 9:00 AM - StreetInsider Form 4 BioNTech SE For: Sep 11 Filed by: Sahin Ugur September 14, 2026 4:51 PM - SEC Filing Form 6-K BioNTech SE For: Sep 14 September 14, 2026 8:29 AM - SEC Filing BioNTech drug shows doubled survival in lung cancer trial September 14, 2026 4:27 AM - StreetInsider BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patie September 14, 2026 4:00 AM - StreetInsider Form 4 BioNTech SE For: Sep 10 Filed by: Sahin Ugur September 11, 2026 5:18 PM - SEC Filing BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts September 8, 2026 7:22 AM - StreetInsider BMO Capital Downgrades BioNTech (BNTX) to Market Perform September 8, 2026 4:36 AM - StreetInsider BioNTech (BNTX) PT Lowered to $136 at Canaccord August 31, 2026 7:08 AM - StreetInsider BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast August 28, 2026 9:46 AM - StreetInsider BioNTech ends colorectal cancer mRNA therapy trial early August 28, 2026 9:09 AM - StreetInsider Form 6-K BioNTech SE For: Aug 28 August 28, 2026 9:06 AM - SEC Filing Form 6-K BioNTech SE For: Aug 27 August 27, 2026 4:55 PM - SEC Filing FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine August 27, 2026 4:30 PM - StreetInsider Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine August 27, 2026 4:30 PM - Globe NewsWire A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity August 26, 2026 9:20 AM - StreetInsider Form 6-K BioNTech SE For: Aug 20 August 20, 2026 7:37 AM - SEC Filing These 25 S&P 500 stocks saw the largest increase in institutional ownership in Q2 August 20, 2026 7:23 AM - StreetInsider BioNTech SE (BNTX) Misses Q2 EPS by 18c August 5, 2026 8:52 AM - StreetInsider Form 6-K BioNTech SE For: Jun 30 August 4, 2026 7:02 AM - SEC Filing Form 6-K BioNTech SE For: Aug 04 August 4, 2026 7:00 AM - SEC Filing Form 6-K BioNTech SE For: Aug 03 August 3, 2026 6:54 AM - SEC Filing Form 20-F/A BioNTech SE For: Dec 31 July 30, 2026 4:23 PM - SEC Filing Form 6-K BioNTech SE For: Jul 29 July 29, 2026 5:08 PM - SEC Filing Full Article List